These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

330 related items for PubMed ID: 1906023

  • 21. Effect of an aldose reductase inhibitor on glomerular basement membrane anionic sites in streptozotocin-induced diabetic rats.
    Isogai S, Inokuchi T, Ohe K.
    Diabetes Res Clin Pract; 1995 Nov; 30(2):111-6. PubMed ID: 8833631
    [Abstract] [Full Text] [Related]

  • 22. Vascular filtration function in galactose-fed versus diabetic rats: the role of polyol pathway activity.
    Pugliese G, Tilton RG, Speedy A, Chang K, Province MA, Kilo C, Williamson JR.
    Metabolism; 1990 Jul; 39(7):690-7. PubMed ID: 2114513
    [Abstract] [Full Text] [Related]

  • 23. Glomerular Na+-K+-ATPase activity in acute and chronic diabetes and with aldose reductase inhibition.
    Cohen MP, Klepser H.
    Diabetes; 1988 May; 37(5):558-62. PubMed ID: 2834250
    [Abstract] [Full Text] [Related]

  • 24. Evaluation of the effect of aldose reductase inhibition on increased basement membrane collagen fluorescence in diabetic rats.
    Cohen MP, Klepser H, Wu VY.
    Gen Pharmacol; 1991 May; 22(4):603-6. PubMed ID: 1936894
    [Abstract] [Full Text] [Related]

  • 25. Intervention with the aldose reductase inhibitor, tolrestat, in renal and retinal lesions of streptozotocin-diabetic rats.
    McCaleb ML, McKean ML, Hohman TC, Laver N, Robison WG.
    Diabetologia; 1991 Oct; 34(10):695-701. PubMed ID: 1959701
    [Abstract] [Full Text] [Related]

  • 26. Effect of octreotide and insulin on manifest renal and glomerular hypertrophy and urinary albumin excretion in long-term experimental diabetes in rats.
    Grønbaek H, Nielsen B, Osterby R, Harris A, Orskov H, Flyvbjerg A.
    Diabetologia; 1995 Feb; 38(2):135-44. PubMed ID: 7536170
    [Abstract] [Full Text] [Related]

  • 27. Amelioration of glomerular hyperfiltration in acute experimental diabetes mellitus by dietary myo-inositol supplementation and aldose reductase inhibition.
    Goldfarb S, Simmons DA, Kern EF.
    Trans Assoc Am Physicians; 1986 Feb; 99():67-72. PubMed ID: 3111062
    [No Abstract] [Full Text] [Related]

  • 28. Substance P levels in peripheral nerve, skin, atrial myocardium and gastrointestinal tract of rats with long-term diabetes mellitus. Effects of aldose reductase inhibition.
    Willars GB, Calcutt NA, Compton AM, Tomlinson DR, Keen P.
    J Neurol Sci; 1989 Jun; 91(1-2):153-64. PubMed ID: 2473171
    [Abstract] [Full Text] [Related]

  • 29. Sequential alterations in glomerular prostaglandin and thromboxane synthesis in diabetic rats: relationship to the hyperfiltration of early diabetes.
    Craven PA, Caines MA, DeRubertis FR.
    Metabolism; 1987 Jan; 36(1):95-103. PubMed ID: 3099125
    [Abstract] [Full Text] [Related]

  • 30. [Role of aldose reductase inhibitors in the development of peripheral neuropathy in experimental diabetes].
    Kuchmerovskaia TM, Donchenko GV, Klimenko AP, Chichkovskaia GV, Pakirbaeva LV, Kozitskiĭ ZIa, Efimov AS.
    Ukr Biokhim Zh (1978); 1997 Jan; 69(3):77-82. PubMed ID: 9505366
    [Abstract] [Full Text] [Related]

  • 31. Reduction of glomerular hyperfiltration in normoalbuminuric IDDM patients by 6 mo of aldose reductase inhibition.
    Pedersen MM, Christiansen JS, Mogensen CE.
    Diabetes; 1991 May; 40(5):527-31. PubMed ID: 1902426
    [Abstract] [Full Text] [Related]

  • 32. The effect of sorbinil, an aldose reductase inhibitor, on aortic function in control and streptozotocin-induced diabetic rats.
    Sellers DJ, Chess-Williams R.
    J Auton Pharmacol; 2000 Feb; 20(1):15-22. PubMed ID: 11048957
    [Abstract] [Full Text] [Related]

  • 33. Effects of combined insulin and sorbinil treatment on diabetes-induced vascular dysfunction in rats.
    Pugliese G, Tilton RG, Speedy A, Oates PJ, Williamson JR.
    Metabolism; 1994 Apr; 43(4):492-500. PubMed ID: 8159110
    [Abstract] [Full Text] [Related]

  • 34. Glomerular basement membrane thickening in streptozotocin diabetic rats despite treatment with an aldose reductase inhibitor.
    Osterby R, Gundersen HJ.
    J Diabet Complications; 1989 Apr; 3(3):149-53. PubMed ID: 2528558
    [Abstract] [Full Text] [Related]

  • 35. Adenosine triphosphatase activity in sciatic nerve tissue of streptozocin-induced diabetic rats with and without high dietary sucrose: effect of aldose reductase inhibitors.
    Sredy J, Flam BR, Sawicki DR.
    Proc Soc Exp Biol Med; 1991 Jun; 197(2):135-43. PubMed ID: 1851565
    [Abstract] [Full Text] [Related]

  • 36. Increased urinary prostaglandin excretion in galactose-fed rats.
    Zager PG, Eaton RP, Frey HJ, Scavini M, Jackson JE.
    Metabolism; 1989 Jul; 38(7):603-5. PubMed ID: 2500576
    [Abstract] [Full Text] [Related]

  • 37. Comparison of the effects of inhibitors of aldose reductase and sorbitol dehydrogenase on neurovascular function, nerve conduction and tissue polyol pathway metabolites in streptozotocin-diabetic rats.
    Cameron NE, Cotter MA, Basso M, Hohman TC.
    Diabetologia; 1997 Mar; 40(3):271-81. PubMed ID: 9084964
    [Abstract] [Full Text] [Related]

  • 38. Effect of aldose reductase inhibitor (tolrestat) on urinary albumin excretion rate and glomerular filtration rate in IDDM subjects with nephropathy.
    Passariello N, Sepe J, Marrazzo G, De Cicco A, Peluso A, Pisano MC, Sgambato S, Tesauro P, D'Onofrio F.
    Diabetes Care; 1993 May; 16(5):789-95. PubMed ID: 8495620
    [Abstract] [Full Text] [Related]

  • 39. The effects of streptozotocin-induced diabetes and aldose reductase inhibition with sorbinil, on left and right atrial function in the rat.
    Sellers DJ, Chess-Williams R.
    J Pharm Pharmacol; 2000 Jun; 52(6):687-94. PubMed ID: 10875546
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.